Artelo Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Artelo Biosciences (ARTL).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

2Buy

2Hold

Consensus RatingBuy# Analysts4Avg. Consensus PT$891Upside to Avg. PT+27231.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 19, 2025	Maxim Group	Jason McCarthy	Downgrade	Buy→Hold	—
Sep 8, 2025	D. Boral Capital	Jason Kolbert	Downgrade	Buy→Hold	—
Aug 26, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$18
Aug 18, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$18
Aug 6, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$18
Aug 4, 2025	D. Boral Capital	Jason Kolbert	PT Cut	Buy	$20→$18
Jul 8, 2025	D. Boral Capital	Jason Kolbert	Upgrade	Hold→Buy	$20
Jun 11, 2025	D. Boral Capital	Jason Kolbert	Downgrade	Buy→Hold	—
Jun 6, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$6
Apr 28, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$6
Apr 2, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$6
Mar 4, 2025	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$5
Mar 3, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$6
Feb 27, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$6
Jan 14, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$6
Dec 9, 2024	D. Boral Capital	Jason Kolbert	Maintained	Buy	$6
Dec 9, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$5
Nov 13, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$5
Oct 1, 2024	EF Hutton	Jason Kolbert	Initiate	Buy	$6
Aug 14, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$5

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Maxim Group Downgrades Artelo Biosciences to Hold

Maxim Group analyst Jason McCarthy downgrades Artelo Biosciences (NASDAQ:ARTL) from Buy to Hold.

Benzinga Newsdesk

This Science Applications International Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday

Avi Kapoor

PRO
D. Boral Capital Downgrades Artelo Biosciences to Hold

D. Boral Capital analyst Jason Kolbert downgrades Artelo Biosciences (NASDAQ:ARTL) from Buy to Hold.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

D. Boral Capital analyst Jason Kolbert maintains Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $18 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

D. Boral Capital analyst Jason Kolbert maintains Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $18 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

D. Boral Capital analyst Jason Kolbert maintains Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $18 price target.

Benzinga Newsdesk

Artelo Biosciences Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Artelo Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Maxim Group Downgrades Artelo Biosciences to Hold

This Science Applications International Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday

PRO
D. Boral Capital Downgrades Artelo Biosciences to Hold

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

People Also Watch

People Also Watch

Artelo Biosciences Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Artelo Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROMaxim Group Downgrades Artelo Biosciences to Hold

This Science Applications International Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday

PROD. Boral Capital Downgrades Artelo Biosciences to Hold

PROD. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

PROD. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

PROD. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

People Also Watch

People Also Watch

PRO
Maxim Group Downgrades Artelo Biosciences to Hold

PRO
D. Boral Capital Downgrades Artelo Biosciences to Hold

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target